Provided by Tiger Trade Technology Pte. Ltd.

Permian Resources Corp

23.75
-0.1200-0.50%
Post-market: 23.760.0100+0.04%19:57 EDT
Volume:8.93M
Turnover:212.56M
Market Cap:19.89B
PE:15.02
High:24.00
Open:23.92
Low:23.60
Close:23.87
52wk High:24.09
52wk Low:11.92
Shares:837.29M
Float Shares:794.89M
Volume Ratio:0.90
T/O Rate:1.12%
Dividend:0.62
Dividend Rate:2.61%
EPS(TTM):1.58
EPS(LYR):1.28
ROE:11.40%
ROA:7.54%
PB:1.66
PE(LYR):18.55

Loading ...

Permian Resources (PR) Gets a Buy from Wells Fargo

TIPRANKS
·
Jul 04

Permian Resources is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jun 30

Permian Resources price target lowered to $24 from $25 at Morgan Stanley

TIPRANKS
·
Jun 29

How Investors Are Reacting To Permian Resources (PR) Broad Russell Growth Index Inclusion

Simply Wall St.
·
Jun 29

Is Permian Resources (PR) Undervalued As Evercore Starts Coverage Following Its Q1 Earnings Beat?

Simply Wall St.
·
Jun 27

The Lurid Lawsuit, Salami Scandal and Trash-can Thief Vexing Jpmorgan's PR Dept.

Dow Jones
·
Jun 25

Livesense Sets Up Subsidiary to Tackle AI-Driven Technical PR Challenges

MT Newswires Live
·
Jun 24

Livesense to Launch Technical PR Subsidiary to Bolster Engineer Recruitment Services

TIPRANKS
·
Jun 24

Permian Resources Initiated at Outperform by Evercore ISI Group

Dow Jones
·
Jun 23

Permian Resources initiated with an Outperform at Evercore ISI

TIPRANKS
·
Jun 23

Evercore ISI Initiates Permian Resources at Outperform With $25 Price Target

MT Newswires Live
·
Jun 23

Motor finance revs up City watchdog’s PR spend

cityam
·
Jun 22

COP, PR, and FANG Stocks Rise as Roth Capital Upgrades to Buy after Recent Pullback

TIPRANKS
·
Jun 22

Roth Capital Partners Upgrades Permian Resources to Buy From Neutral, Adjusts PT to $23 From $22

MT Newswires Live
·
Jun 22

Permian Resources upgraded to Buy from Neutral at Roth Capital

TIPRANKS
·
Jun 22

Permian Resources Corp : Raymond James Cuts Target Price to $26 From $29

THOMSON REUTERS
·
Jun 17

Private Equity's Push Into 401(k)s Has a Big PR Problem -- Barrons.com

Dow Jones
·
Jun 16

PR TIMES Issues Restricted Shares to Strengthen Equity-Based Remuneration

TIPRANKS
·
Jun 12

C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population

GlobeNewswire
·
Jun 11

3 Debt-Free Small-Cap Stocks with Growing Dividends

The Smart Investor
·
Jun 08